5HT6 Antagonists in the Treatment of Alzheimer's Dementia: Current Progress.

about

5HT6 Antagonists in the Treatment of Alzheimer's Dementia: Current Progress.

Item

http://www.wikidata.org/entity/Q55208636

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

5HT6 Antagonists in the Treatment of Alzheimer's Dementia: Current Progress.

@en

5HT6 Antagonists in the Treatment of Alzheimer's Dementia: Current Progress.

@nl

type

Item

label

5HT6 Antagonists in the Treatment of Alzheimer's Dementia: Current Progress.

@en

5HT6 Antagonists in the Treatment of Alzheimer's Dementia: Current Progress.

@nl

prefLabel

5HT6 Antagonists in the Treatment of Alzheimer's Dementia: Current Progress.

@en

5HT6 Antagonists in the Treatment of Alzheimer's Dementia: Current Progress.

@nl

P1476

5HT6 Antagonists in the Treatment of Alzheimer's Dementia: Current Progress.

@en

P2093

Babak Tousi

http://www.w3.org/2001/XMLSchema#string

Marwan N Sabbagh

http://www.w3.org/2001/XMLSchema#string

Megan Andrews

http://www.w3.org/2001/XMLSchema#string

P2860

5-HT6 receptors and Alzheimer's disease

Serotonergic drugs : effects on appetite expression and use for the treatment of obesity

Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study

AVN-101: A Multi-Target Drug Candidate for the Treatment of CNS Disorders.

Double-blind, controlled phase II study of a 5-HT6 receptor antagonist, SB-742457, in Alzheimer's disease.

AVN-211, Novel and Highly Selective 5-HT6 Receptor Small Molecule Antagonist, for the Treatment of Alzheimer's Disease.

Serotonin signaling is associated with lower amyloid-β levels and plaques in transgenic mice and humans

The benefits and risks associated with cholinesterase inhibitor therapy in Alzheimer's disease.

The effects of PRX-07034, a novel 5-HT6 antagonist, on cognitive flexibility and working memory in rats.

Therapeutics of Alzheimer's disease: Past, present and future.

P2888

s40120-018-0095-y

P304

51-58

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40120-018-0095-Y

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-05-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1103815304

http://www.w3.org/2001/XMLSchema#string

P698

29728891

http://www.w3.org/2001/XMLSchema#string

P932

5990506

http://www.w3.org/2001/XMLSchema#string